^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners

    TEST:
    EpiCapture Test

    Company:
    Trinity Biotech
    Type:
    Laboratory Developed Test

    Details

    Evidence
    News
    EpiCapture’s innovative urine-based test is designed to reduce the need for repeated invasive prostate biopsies for patients undergoing active surveillance for prostate cancer. The test offers a breakthrough approach to monitoring disease progression by using epigenetic analysis to detect DNA methylation patterns that are indicative of high-grade cancer.
    Cancer:
    Prostate Cancer
    Method:
    Next-Generation Sequencing (NGS)